chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I started experience some symptoms around three weeks post my booster. I began to start to have a general dizziness that was coming on out of nowhere. Positional, and very persistent vertigo that kept going all day. I was beginning to feel depressed, unstable walking, and feeling generally unwell. I called my doctor and had a virtual meeting with him and got COVID-19 test and flu test that were both negative. My doctor did prescribe a Z-PAK steroid and antibiotic as well. After taking it for 8-10 days I had minimal success in improving symptoms and so I then went to a chiropractor, where some did improve drastically almost immediately, however the symptoms did return on the 4th of July, and did go see the chiropractor as well. I did also see an acupuncturist as well. Right now, I am feeling well, symptoms are definitely minimal if anything. The acupuncturist thought that there may be inflammation as well that's causing these issues. Saw a cardiologist as well and he did not find anything going on with my cardiovascular system.
began w/red, sore, swollen lt arm @ inj site;had raised red rash, & pain @ inj site;also these sx lasted 1wk;cont to have pain in arm lt arm-becomes more painful when moved;saw MD 8NOV96 given med, warm compresses
Patient administered 0.3ml of Pfizer, that was diluted with 0.8ml diluent
tingling / in her left foot; numbing in her left foot / foot is asleep; This case was reported by a consumer via call center representative and described the occurrence of tingling of extremity in a 69-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 5th December 2020, the patient received Shingrix. On 5th December 2020, immediately after receiving Shingrix, the patient experienced tingling of extremity and numbness in feet. On an unknown date, the outcome of the tingling of extremity and numbness in feet were not recovered/not resolved.   It was unknown if the reporter considered the tingling of extremity and numbness in feet to be related to Shingrix.  Additional details were provided as follows: The patient reported case for hrself. The patient reported tingling and numbing in her left foot that presented shortly after received the vaccine. She described it as her foot was asleep No additional details provided. The reporter did not consent to follow up.
Wet with sweat; Weak; (Arm) was red; (Arm) was swollen; Joint Pain where I could hardly walk; Fever; Chills; Joint Pain; This spontaneous case was reported by a consumer and describes the occurrence of HYPERHIDROSIS (Wet with sweat), ASTHENIA (Weak), ERYTHEMA ((Arm) was red), PERIPHERAL SWELLING ((Arm) was swollen) and GAIT DISTURBANCE (Joint Pain where I could hardly walk) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 052E21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 in July 2021. Concurrent medical conditions included Graves' disease.    On 20-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Aug-2021, the patient experienced HYPERHIDROSIS (Wet with sweat), ASTHENIA (Weak), ERYTHEMA ((Arm) was red), PERIPHERAL SWELLING ((Arm) was swollen), GAIT DISTURBANCE (Joint Pain where I could hardly walk), PYREXIA (Fever), CHILLS (Chills) and ARTHRALGIA (Joint Pain). On 28-Aug-2021, GAIT DISTURBANCE (Joint Pain where I could hardly walk), PYREXIA (Fever), CHILLS (Chills) and ARTHRALGIA (Joint Pain) had resolved. At the time of the report, HYPERHIDROSIS (Wet with sweat), ASTHENIA (Weak), ERYTHEMA ((Arm) was red) and PERIPHERAL SWELLING ((Arm) was swollen) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant and treatment medications were provided
Developed severe headache, then oversensitivity to sound and tinnitus--worse on the same side as vaccine injection.   While the symptoms have diminished somewhat, they persist
Rheumatoid arthritis flare up; This spontaneous case was reported by a consumer and describes the occurrence of RHEUMATOID ARTHRITIS (Rheumatoid arthritis flare up) in an adult female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Rheumatoid arthritis.   On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form and third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced RHEUMATOID ARTHRITIS (Rheumatoid arthritis flare up) (seriousness criterion medically significant). The patient was treated with ADALIMUMAB (HUMIRA) (subcutaneous) for Rheumatoid arthritis, at a dose of 1 dosage form. At the time of the report, RHEUMATOID ARTHRITIS (Rheumatoid arthritis flare up) outcome was unknown.            Relevant concomitant medications were not reported. Patient received first, second and booster dose from Moderna COVID-19 vaccine.  Company comment: This spontaneous case concerns a female patient of an unknown age, with relevant medical history of rheumatoid arthritis, who experienced the unexpected serious (medically significant) AESI of Rheumatoid arthritis (reported as Rheumatoid arthritis flare up) after receiving the booster dose of mRNA-1273 vaccine. The onset date of the event was not reported. Patient received 2 doses of mRNA-1273 vaccine (dates not reported). Patient took Adalimumab (Humira) as a treatment regimen. Clinical course was not reported. The outcome of event was unknown. The medical history of rheumatoid arthritis remains as a confounder. The benefit-risk relationship of mRNA-1273 is not affected by this report. Event's seriousness was assessed based on medical judgement.; Sender's Comments: This spontaneous case concerns a female patient of an unknown age, with relevant medical history of rheumatoid arthritis, who experienced the unexpected serious (medically significant) AESI of Rheumatoid arthritis (reported as Rheumatoid arthritis flare up) after receiving the booster dose of mRNA-1273 vaccine. The onset date of the event was not reported. Patient received 2 doses of mRNA-1273 vaccine (dates not reported). Patient took Adalimumab (Humira) as a treatment regimen. Clinical course was not reported. The outcome of event was unknown. The medical history of rheumatoid arthritis remains as a confounder. The benefit-risk relationship of mRNA-1273 is not affected by this report. Event's seriousness was assessed based on medical judgement.
Patient is a 53 year old male who presents for an injection reaction. Wednesday had the pneumonia shot (indication: Smoker). Then after that in the middle of the night he felt the site to be hot and hurting. The following day, around the Band Aid there was redness about 6 cm. This has increased since and pain has been more apparent as well. He has felt "under the weather." He has had joint achiness in general but no joints that are red or swollen. The patient denies fever, chills, sweats or rash. The achiness may have started last weekend with a cold, nasal congestion. No facial or sinus pain, just congestion. Using MUCINEX, daily; ALKA SELTZER. No breathing issues. He has had neck pains but this is usual for him, preceded the PNEUMOVAX. He has not had vaccine reactions in the past. WORK: does physical work and a lot of lifting.
This spontaneous report as received from a certified medical assistant refers to a 20 year old patient of unknown gender who on 16-FEB-2015 was inadvertently vaccinated with a dose of ZOSTAVAX (dose, lot #, expiration date and route were not reported). No adverse effects were reported. It was unknown if the patient sought medical attention. Additional information has been requested.
11/11/2022, I went to Dr. for a history of burning while urinating for several weeks. I had groin pain and frequent urination but no blood or discharge in the urine. He did urine and blood tests, negative. Levaquin was prescribed. After 2 weeks, symptoms came back.  I was put on a high dose for 3 weeks. I was referred to a Urologist. I will see the Urologist this week.
Narrative: 67 y/o female with paroxysmal Afib who experienced syncope at home, fell and hit her head. she tested + for COVID w/o symptoms. +CT findings for pneumonia-mild. No arrythmia while in ED; however, findings concerning for arrythmia induced syncope. Assessment: Syncope COVID PNA Afib Patient had mild symptoms of achinness x1 week but no other covid symptoms. CTA chest consistent with mild pneumonia. Stayed in hospital for syncope workup, discharged home after 24 hours.
Severe brain fog, impaired focus and concentration starting early February 2021. The impaired mental status negatively affected vaccine recipient's job performance to a significant degree; this lead to severe and currently ongoing episodes of anxiety and depression. Vaccine recipient is currently taking multiple psych meds and going through therapy sessions. Vaccine recipient has no prior history of anxiety or depression.
Late menstrual cycle. My cycle is very regular, the same flow every month, coming on the 25th day and rarely late. I only had spotting on what would've been the first day of my period. The spotting occurred for 2 days and that was it - no regular flow. I'm still waiting for my regular period to come. It's now almost 5 days late. I've read on many social media boards that this is happening to a lot of women. Please make the information about late/abnormal periods public knowledge!
Severe chills during the first night (unsure what time) and fever of 101.6F.  Day after, spent all day in bed with fever between 100-101F and some minor aches. Swollen injection site. Next day, still slight fever (<100) and slight aches; more than half the day in bed. Wednesday morning close to normal and out of bed.
Approximately 3 hours post vaccination, patient developed chills, a fever to 103F. Then felt dizzy, had a pre-syncopal event with nausea, severe headache and vision changes. No true syncope.  No vomiting.   Headache, dizziness, vision changes and lightheadedness improved with rest. Still febrile 103F about 5 hours post vaccine administration.
It was reported in a newspaper article that children, ages 12 months through 23 months, who were vaccinated with a dose of PROQUAD suffered higher rates of fever related convulsions than children vaccinated with two separate shots, one for chickenpox and one for the three other diseases. The study reported that the rate of seizures was twice as high, which translates to about one extra case of convulsion for every 2,000 doses administered. The study focused on children who develop fevers and then go into convulsions, an occurrence that frightens parents but usually has no lingering consequences. There were no deaths in the study. Upon internal review, febrile convulsions was considered to be an other important medical event. Additional information is not expected.
TIRED AND FATIGUE; This spontaneous report received from a patient concerned a female of unspecified age. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose was not reported, administered on 23-JUN-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On an unspecified date, the subject experienced tired and fatigue. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from tired and fatigue. This report was non-serious.
9 days after vaccine was received in the left arm , there was swelling , redness , warmth and pain at the site . I took 600mg Ibuprofen every 6 hours for about 30 hours and I placed ice at the site frequently. I saw my PA next day and I was prescribed a Medrol pack , which helped resolve all those symptoms after first day of taking the medication.
Information has been received from a registered nurse referring to a boy patient of unknown age. The patient's medical history, concurrent condition and other concomitant medication were not reported. On 27-OCT-2017, the patient was vaccinated with improperly stored Oka/Merck VARIVAX (dose, route unknown, lot # N017396 with expiration date 07-JUN-2019) for prophylaxis. The sterile diluent (manufacturer unknown) (unknown lot number and expiration date) used for reconstitution was properly stored. The vaccine was exposed to temperature excursion of -14 degree Celsius to -10 degree Celsius for a time frame of 2 hours. There were no previous temperature excursions. Data logger was involved. No product quality complaint (PQC) was involved in this case. No adverse effects reported. This is one of several reports received from the same reporter. Sender's Comments: US-009507513-1805USA011819: US-009507513-1805USA011818: US-009507513-1805USA011820: US-009507513-1805USA011821: US-009507513-1805USA011822.
Sterile water preservative free) used instead of  sodium chloride.  Error was recognized after recipient left the clinic.  CDC notified.  Recommended immediate repeat since this dose is invalid.   Parent notified who declined and wanted to wait 3 weeks before repeating this first dose
very hot in the area of the injection; weal appeared in the injection site; weal appeared in the injection site that was a little swollen; palpitations; pain in the injection arm to the middle of her elbow; This spontaneous case was reported by a consumer and describes the occurrence of PALPITATIONS (palpitations), VACCINATION SITE WARMTH (very hot in the area of the injection), VACCINATION SITE ERYTHEMA (weal appeared in the injection site), VACCINATION SITE PAIN (pain in the injection arm to the middle of her elbow) and VACCINATION SITE SWELLING (weal appeared in the injection site that was a little swollen) in a 41-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 005C21A) for COVID-19 vaccination.     Concurrent medical conditions included Depression.    On 14-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Aug-2021, the patient experienced PALPITATIONS (palpitations) and VACCINATION SITE PAIN (pain in the injection arm to the middle of her elbow). On 22-Aug-2021, the patient experienced VACCINATION SITE ERYTHEMA (weal appeared in the injection site) and VACCINATION SITE SWELLING (weal appeared in the injection site that was a little swollen). On 23-Aug-2021, the patient experienced VACCINATION SITE WARMTH (very hot in the area of the injection). On 15-Aug-2021, PALPITATIONS (palpitations) had resolved. On 17-Aug-2021, VACCINATION SITE PAIN (pain in the injection arm to the middle of her elbow) had resolved. At the time of the report, VACCINATION SITE WARMTH (very hot in the area of the injection), VACCINATION SITE ERYTHEMA (weal appeared in the injection site) and VACCINATION SITE SWELLING (weal appeared in the injection site that was a little swollen) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications include Pill for depression to help sleep.  No treatment information was mentioned.
I have a herpes outbreak on my face under my left eye. I have never had one there before, but I have had one on my chin a few years ago. I believe this is directly related to the vaccine.
Throat itching and coughing treated with cetirizine, albuterol, and Epi. No hives, no GI symptoms, no wheezing or hypotension.
Erythema noted at injection site. Rx Claritin 10 x 3-9 days with relief.
SKIN DISORDER; COLDNESS OF SKIN; This spontaneous report received from a patient concerned a 65 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included: moderate to severe chronic plaque psoriasis. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number was not reported) dose was not reported, administered on 01-MAR-2021 for prophylactic vaccination. The batch number was not reported. The company is unable to perform follow-up to request batch/lot numbers.  Non-company suspect drugs included: risankizumab (form of admin unknown, subcutaneous, batch number was not reported) dose, frequency, and therapy dates were not reported for moderate to severe chronic plaque psoriasis. No concomitant medications were reported. On an unspecified date, the patient experienced skin disorder, and coldness of skin. The action taken with covid-19 vaccine ad26.cov2.s was not applicable; and action taken with risankizumab was not reported. The patient recovered from coldness of skin, and had not recovered from skin disorder. This report was non-serious.
I am experiencing what I have researched to be "vaccine arm". My arm started aching late in the evening on Tuesday 7/20, feeling like it had immediately after getting the vaccine. I woke up the Wednesday morning in quite a lot of pain shooting from my shoulder to my wrist. My left arm aching so bad I could hardly move it and grasping things in my hand hurt. I took some Advil which seemed to help very little and went to work. My arm ached badly throughout the day, but seemed to loosen up some. Around 4pm I noticed the area around where I had gotten the injection more than a week before was starting to get a little red and swollen. By 9pm the area had spread and was red, swollen and now warm to the touch. The arm still aches all the way from my shoulder to wrist, but it isn't quite as bad as it had been in the morning.
Woke up at 5:24AM with a huge pain in the left calf and it woke me up and it took a few minutes to reduce the pain. I had to stand up and try to stretch my leg but it still hurt. Touching the area it feel like a hard muscle ball and I had to massage the area for a few minutes to be bearable. Almost 04 hours after the event it still sore and hurt when I move my leg or try to walk. The only other time I remember having such  muscle pain was tearing some muscles playing soccer years ago.
pt recv vax;exp papular rash;more extensive than previously and involved most of the thigh to the knee;rash lasted for a short period of time & then disappeared;
Breakthrough case admission after 4 vaccines Moderna 2/1/21 Lot# 031L20A;  Moderna 3/11/21 Lot# 044A21A;  Moderna 12/10/21 Lot# 060H21A;  Moderna 11/2/22 Lot# 053D22A
Red, Warmth and pain at injection site.  Noticed on subsequent admission to hospital for a different reason
p/vax mom report pt became stiff arched back, eyes rolled, pale, no T-C action, +loss of urine lasted 3-5seconds;pt awoke cried;
approximately 8 hrs after administration, experienced significant pain in the arm where the vaccine was administered (5 on a 1 to 10 scale).  Was unable to raise that arm.  24 hrs after administration the pain had lessened and was more generalized.  Approx 26 hrs after administration noticed a generalized red, raised rash overing a 3 inch by 6 inch area on the top of the arm where the vaccine was administered.  There is slight, generalized swelling where the rash is located.  Discomfort is now slight.
1. Left arm was puffy and very sore around the injection site (within ~2 inches of the injection site). 2. During the night, I was very cold and shivering for several hours.
Received their first dose after vaccine was open in refrigerator over 12 hour expiration time; This spontaneous case was reported by a health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Received their first dose after vaccine was open in refrigerator over 12 hour expiration time) in a 42-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 005C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 14-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-May-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Received their first dose after vaccine was open in refrigerator over 12 hour expiration time). On 14-May-2021, EXPIRED PRODUCT ADMINISTERED (Received their first dose after vaccine was open in refrigerator over 12 hour expiration time) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medication list was not provided. Treatment information was not provided. The reporter states that on 13 May 2021, a vial, lot 005C21A, was punctured at 11:25 AM to administer a dose to a patient. The vaccine sat in the refrigerator overnight and on 14/May/2021 between 9:45 to 10 30 AM, a female patient received their first dose.   This case was linked to MODERNATX, INC.-MOD-2021-138655 (E2B Linked Report).; Sender's Comments:  MODERNATX, INC.-MOD-2021-138655:Crosslinked: Same Reporter
Dizziness, light headedness, shortness of breath, resting pulse not lower than 120 (monitored for 45 minutes), migraine for 3 days
skin melanoma; This is a spontaneous report from a contactable consumer (patient). A female patient of an unspecified age received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number and expiry date: unknown), via an unspecified route of administration on an unspecified date as single dose for COVID-19 immunization. The patient medical history and concomitant medications were not reported. Patient said she had surgery for her skin melanoma on Monday (unspecified date), and received her second dose of the Pfizer-BioNTech Covid-19 Vaccine on Friday. She wants to know if the Novocaine they gave her during the surgery affected the vaccine. They told the patient that there is no information in the Pfizer-BioNTech Covid-19 Vaccine Prescribing Information about a potential interaction or administration with Novocaine. They also referred the patient to her HCP for more guidance. Patient said she had no problems with the first dose of the Pfizer-BioNTech Covid-19 Vaccine. On 20Apr2021, the patient was calling about the COVID 19 vaccine. She had the vaccine 3 weeks ago and she had no side effects or symptoms and she had received text messages everyday to see how she was feeling everything and she always answered none or no. Patient declined to complete report at this time wished to be transferred to MI for her question. The outcome of the event was unknown. Therapeutic measures were taken as a result of skin melanoma.  Information on the lot/batch number has been requested.
Initial report received on 06 March 2008 from a health care professional.  An 18-year-old female patient, who was taking TOPAMAX and PREVACID, and who had no past obstetrical history, but did have past medical history of migraines, acne, "GERD", and allergic rhinitis, had received a right arm booster dose of ADACEL, a dose of GARDASIL (Manufacturer Merck), and a dose of "Hep A" vaccine (manufacturer Merck) on 12 February 2008.  The lot numbers, routes and sites of administration for the GARDASIL and "Hep A" vaccines were not provided.  The route of administration for the ADACEL was also not provided.  The patient then "conceived 14 February 2008", and had a positive pregnancy test on 02 March 2008.  The date of the patient's last menstrual period was not provided.  It was not reported whether the patient had experienced any adverse events since vaccination with ADACEL, GARDASIL, and "Hep A".